Société Synta Pharmaceuticals Corp. Nasdaq
Actions
US87162T2069
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Edward Chiang
FOU | Founder | - | 01/09/11 |
William Sibold
CEO | Chief Executive Officer | 57 | 08/09/23 |
Rebecca Taub
FOU | Founder | 71 | 01/07/16 |
Ronald Filippo
CTO | Chief Tech/Sci/R&D Officer | - | 21/11 |
Stephen Dodge
CTO | Chief Tech/Sci/R&D Officer | - | - |
Paul Friedman
BRD | Director/Board Member | 81 | 22/07/16 |
Tina Ventura
IRC | Investor Relations Contact | - | 29/01 |
Carole Huntsman
PRN | Corporate Officer/Principal | 59 | - |
Corporate Officer/Principal | - | 10/01/22 | |
Corporate Officer/Principal | 61 | 02/08/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Fred Craves
FOU | Founder | 78 | 01/09/11 |
Julian Baker
CHM | Chairman | 57 | 15/06/23 |
Ken Bate
BRD | Director/Board Member | 73 | 22/07/16 |
Paul Friedman
BRD | Director/Board Member | 81 | 22/07/16 |
Richard Levy
BRD | Director/Board Member | 66 | 11/08/16 |
Rebecca Taub
FOU | Founder | 71 | 01/07/16 |
William Sibold
CEO | Chief Executive Officer | 57 | 08/09/23 |
James Daly
BRD | Director/Board Member | 62 | 27/06/19 |
Raymond Cheong
BRD | Director/Board Member | 42 | 15/06/23 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 21 311 526 | 17 647 937 ( 82,81 %) | 0 | 82,81 % |
Coordonnées société
Madrigal Pharmaceuticals, Inc.
200 Barr Harbor Drive Suite 200
19428, West Conshohocken
+267 824 2827
http://www.madrigalpharma.com![Adresse Synta Pharmaceuticals Corp.](https://cdn.zonebourse.com/static/address/42507.png)
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+15,58% | 122 Md | |
+16,60% | 113 Md | |
+17,55% | 26,22 Md | |
-24,33% | 19,01 Md | |
-19,14% | 15,71 Md | |
-17,95% | 15,22 Md | |
-46,81% | 14,72 Md | |
+58,78% | 14,58 Md | |
+4,91% | 13,84 Md |
- Bourse
- Actions
- Action MDGL
- Action
- Société Synta Pharmaceuticals Corp.